Table 1.

Expression of PD-L1 among 34 human lymphoma cell lines

Cell lineLymphoma subtypePD-L1PD-L2
B cell
 DaudiBurkitt
 RajiBurkitt
 RamosBurkitt
 BJA-BBurkitt
 MC116Burkitt
 NU-DHL-1DLBCL (GCB)
 OCI-Ly-2DLBCL (GCB)
 OCI-Ly-7DLBCL (GCB)
 OCI-Ly-19DLBCL (GCB)
 SU-DHL-4DLBCL (GCB)
 SU-DHL-6DLBCL (GCB)
 SU-DHL-2DLBCL (ABC)
 U2932DLBCL (ABC)
 OCI-Ly-3DLBCL (ABC)
 OCI-Ly-10DLBCL (ABC)++
 HBL-1DLBCL (ABC)+
 RC-K8DLBCL (NF-κB+)+
 SU-DHL-5DLBCL
 SU-DHL-7DLBCL
 SU-DHL-8DLBCL
 SU-DHL-9DLBCL
 SU-DHL-10DLBCL
 SU-DHL-16DLBCL
 USC-DHL-1DLBCL
 Granta-519Mantle cell
 JeKo-1Mantle cell
 REC-1Mantle cell
 BCBL-11° effusion
T cell
 Karpas 299ALCL++
 SU-DHL-1ALCL++
 SUP-M2ALCL++
 DELALCL+
 JurkatT-ALL+
 Hut78Sezary syndrome

NOTE: Expression of PD-L1 and PD-L2 was measured by flow cytometry. “++” indicates ≥2 log MFI above isotype control; “+” indicates < 2 logs MFI above control.

Abbreviation: T-ALL, precursor T acute lymphoblastic leukemia.